Korea Zinc shareholders ask court to block share sale in $7.4 billion US project

Korea Zinc shareholders ask court to block share sale in $7.4 billion US project
Source link

Korea Zinc shareholders ask court to block share sale in $7.4 billion US project
Source link
This content is for members only Source link
Stablecoins may drum up $1.4 trillion of extra dollar demand by 2027, JPM says Source link
Broadcom taps Alphabet executive Amie Thuener as next CFO Source link
Cathay General Bancorp 2025 Q1 – Results – Earnings Call Presentation Source link
Frank SagnierGroup Interim Executive Chair Good morning, and welcome to everplay interim results presentation. I am Frank Sagnier, Exec Chair. I am here with my colleagues, Rashid Varachia, CFO and COO; and James Targett, our IR. Let’s start straight away. We’ve had a strong — we’re waiting for a strong full year. The key headline…
Telix Pharmaceuticals (NASDAQ:TLX) executives highlighted commercial momentum in prostate cancer imaging and outlined multiple clinical programs in oncology during an H.C. Wainwright discussion featuring CEO Chris Behrenbruch and CMO David Cade. Company overview and 2026 revenue outlook Behrenbruch Source link